Table 1.
Baseline Characteristics.
| Characteristic | All (n = 16,537) | Suspected Cases (n = 16,189) | Complete Data on Screened patient (n = 3154) | Confirmed Cases (n = 348) | p-value* |
|---|---|---|---|---|---|
| Age – Years | 40 (0.11) | 40 (0.14) | 40 (0.24) | 52 (0.31) | <0.001 |
| Male Sex | 53% | 53% | 51% | 62% | <0.001 |
| Hypertension | – | – | 19% | 21% | 0.42 |
| Diabetes | – | – | 16% | 22% | 0.02 |
| Coronary Heart Disease | – | – | 9% | 7% | 0.49 |
| Chronic Kidney Disease | – | – | 3.6% | 5.8% | 0.1 |
| Asthma/COPD | – | – | 1.2% | 1.9% | 0.4 |
| Metformin | – | – | 14% | 19% | 0.15 |
| Sulfonylureas | – | – | 1.2% | 1.7% | 0.4 |
| DDP4 inhibitors | – | – | 0.8% | 0 | 1 |
| Diuretics | – | – | 9% | 13% | 0.03 |
| ACEI/ARB | – | – | 16% | 15% | 0.4 |
| BB | – | – | 3% | 4.2% | 0.48 |
Data presented as mean (standard error) or percent; *p-value for the comparison of suspected cases versus confirmed cases.
ACEI/ARB = angiotensin-converting enzyme inhibitor and/or receptor blocker, BB = beta blocker.